BioCardia (BCDA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BCDA BioCardia

Watchlist

2.260
+0.125+5.85%

Close Nov 22 16:00 ET

2.300
+0.040+1.77%

Post 20:01 ET

10.36MMarket Cap-560P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BioCardia Third Quarter 2024 Earnings: US$0.61 Loss per Share (Vs US$1.79 Loss in 3Q 2023)
Yahoo FinanceNov 16 08:04 ET
BioCardia Shares Are Trading Higher. The Company Reported Q3 Financial Results.
BenzingaNov 14 15:27 ET
Express News | BioCardia Shares Are Trading Higher. The Company Reported Q3 Financial Results
BenzingaNov 14 15:27 ET
BioCardia's Strong Q3 Performance and Strategic Trials Drive Buy Rating
TipRanksNov 14 06:16 ET · Ratings
10-Q: Q3 2024 Earnings Report
SECNov 13 22:33 ET · Announcements
BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 13 20:14 ET · Conference Call

Comments

Remember Top Line Data 1Q 2025

$BioCardia (BCDA.US)$

$BioCardia (BCDA.US)$
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
BioCardia has completed its Phase III CardiAMP HF trial, a randomized, double-blind, placebo-controlled study evaluating the CardiAMP Cell Therapy System for heart failure treatment. The trial enrolled 125 patients across 18 US hospitals, with 115 patients randomized 3:2 between treatment and control groups. The therapy, which received FDA Breakth...

1

$BioCardia (BCDA.US)$ same unregistered brokerage

$BioCardia (BCDA.US)$ 3$ offering yall

1

1

$BioCardia (BCDA.US)$ BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced at-the-Market Under Nasdaq Rules

1

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data